C

Curia

End-to-end drug development and manufacturing

Customer Quality Lead - Quality Assurance

Full-TimeUpdated on 10/4/2026
$117k - $146.5k+ Relocation assistance
Expert
Bachelor's
Rensselaer, NY, USA
In PersonRelocation assistance is available.

About the job

Requirements
  • A minimum Bachelor of Science degree in Biology or a related scientific field is required.
  • A minimum of 10–15 years of experience in quality assurance, active pharmaceutical ingredient process development, technical services, or good manufacturing practice compliance within the pharmaceutical industry at U.S. Food and Drug Administration-regulated facilities is required.
  • Working experience managing global customers and global cross-functional teams is required.
  • Broad knowledge of current good manufacturing practices, Food and Drug Administration and international regulations—including 21 CFR Parts 11, 210, 211, and 820, European Union good manufacturing practice, and International Council for Harmonisation Q7—and quality systems for active pharmaceutical ingredients is required.
  • Familiarity with Food and Drug Administration and International Council for Harmonisation guidelines is required.
  • Knowledge of pharmaceutical manufacturing operations is required.
  • U.S. Food and Drug Administration inspection experience, such as participating in or interacting with investigators, is required.
  • The ability to work cross-functionally across internal stakeholders, along with communication, organizational, negotiation, influencing, and collaboration skills, is required.
  • Proficiency in building consensus, negotiating, escalating issues, and providing customer service is required.
  • A good understanding of the importance and use of quality metrics is required.
  • Passing a background check and drug screen is required; passing occupational health screening may also be required.
Responsibilities
  • Demonstrate exemplary customer quality service to internal and external customers; the position reports to the site Quality Head.
  • Write and review customer product investigations; coordinate with Quality Assurance to address customer comments related to batch records; and ensure product lots are dispositioned in a timely manner to meet customer needs.
  • Coordinate and/or prepare temporary or planned change controls associated with customer products as needed.
  • Ensure timely completion of customer commitments and regulatory commitments specific to customer projects, supporting the site Quality Head.
  • Ensure timely completion of annual product reviews and assessment of continued process verification and validation activities.
  • Serve as the primary point of contact for customer-related queries from Sales and Business Development teams.
  • Build relationships with stakeholders, including Quality Control, Quality Assurance, and Regulatory Affairs, to obtain and assess data for customer requests or inquiries.
  • Coordinate and assist with customer requests, including requests supporting customer filings and amendments; liaise with Regulatory Affairs and site stakeholders to ensure reviews meet quality agreement requirements.
  • Monitor progress of agreed-upon tasks, escalate issues and delays to the site Quality Head, and prepare contingency plans with internal partners.
  • Review and approve customer complaint investigations; assess root cause analysis; implement corrective and preventive actions; and review their effectiveness.
  • Lead initiatives to improve and harmonize quality processes to improve customer satisfaction.
  • Anticipate customer needs and support the organization and stakeholders in new product introduction activities for Quality Control and Quality Assurance.
  • Maintain sufficient knowledge of the site pipeline to understand customer requests.
  • Participate in customer meetings as required and support product development as needed.
  • Ensure quality assurance agreements are reviewed and approved by Curia and customer stakeholders in a timely manner, and maintain current effective versions.
  • Coordinate with the site Compliance team to schedule customer audits and assist with audits as needed.
  • Lead and drive good manufacturing practice activities associated with customer products and work with Managers and Supervisors to complete related deviation investigations on time.
  • Participate in the site Quality Management Review, provide data as needed, and execute improvement plans.
  • Oversee customer-specific corrective and preventive actions, monitor their completion, and provide updates to customers and management.
  • Interact with the Curia Quality network to share information about quality expectations, inspections, and audits, and facilitate harmonization of the quality system within Curia.
  • May assist QA leadership with mentoring and coaching QA Specialists, as requested.

About the company

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.